A research blog from the NCI Division of Cancer Prevention
Research Highlights: Barrett’s Esophagus Translational Research Network (BETRNet) Studies Provide Insights into Prevention and Risk for Esophageal Cancer
January 30, 2024 | By Susan JenksFindings from two studies aimed at learning more about preventing the type of esophageal cancer with the fastest growing incidence rate have emerged recently from the Barrett’s Esophagus Translational Research Network (BETRNet) as it winds down its collaborative activities.
NCI Launches Network to Study Self-Collection for HPV Testing to Prevent Cervical Cancer
January 25, 2024 | By DCP StaffOn January 25, 2024, the National Cancer Institute (NCI), part of the National Institutes of Health, with public and private partners, is launching a new clinical trial network to gather data on a “self-collection” method of human papillomavirus (HPV) testing to prevent cervical cancer. This method, if determined viable, could open new opportunities for improving uptake of cervical cancer screening.
Research Highlights: Investigating Ways to Reduce and Avoid Side Effects of Medications for Breast Cancer Risk Reduction
December 15, 2023 | By DCP StaffThere are many approved medications for reducing breast cancer risk, but they can cause toxic side effects that lead people to forego preventive interventions. Two recent NCI-supported studies looked at ways to provide breast cancer risk reduction while reducing the chance of adverse side effects.
Research Highlights: How Western-Style Diet, Aging, May Impact Cancer Risk in Intestinal Cells
October 25, 2023 | By DCP StaffA healthier diet has been associated with reduced risk of cancer, but the mechanisms of how that actually works continue to be investigated. In two recent studies, researchers are looking to understand the process on a molecular level.
Research Highlights: Repurposing Common Medications to Prevent Cancer
September 11, 2023 | By DCP StaffTwo recent publications focus on widely used treatments for other diseases to evaluate possible roles in the prevention of cancer. One looked at the potential of statins, a common heart disease drug, to prevent gynecologic cancers, and the other examined whether metformin, a drug for type 2 diabetes, could reduce the risk for breast cancer development. In both studies, investigators relied on a growing understanding of the anti-cancer mechanisms of each drug to assess efforts to repurpose them for cancer use.
Collaboration Spurs Rapid Growth and Progress in Cardio-Oncology Research
August 8, 2023 | By DCP StaffCardio-oncology research looks at cancer treatment-related cardiotoxicity, or damage to the heart and cardiovascular system (including heart valves and vessels) that can occur during or after cancer treatment. Over the last decade, efforts from the National Cancer Institute (NCI) in this area, as well as the field in general, have expanded significantly.
U.S. Study Shows HPV Antibodies Remain High Up to 2 Years After a Single Dose of HPV Vaccine
July 18, 2023 | By Linda WangAfter receiving an initial single dose of the HPV vaccine Gardasil 9, children aged 9 to 11 had high levels of two key antibodies that protect against HPV infections and cancer for up to 2 years before receiving their delayed booster dose, according to results from a clinical trial supported by NCI.
Important Symptom Management Findings Presented at 2023 ASCO Meeting
June 13, 2023 | By DCP StaffResults from two NCI-supported studies relating to symptom management were among the significant findings presented at the June 2023 ASCO meeting. The findings, which both incorporated data from patient-reported outcomes (PROs), have the potential to help reduce toxic side effects and improve quality of life for people with cancer.
Research Highlights: Investigating Associations of Obesity with Colorectal and GI Cancers
June 5, 2023 | By DCP StaffAn estimated 153,020 men and women in the U.S. will be diagnosed with colorectal cancer in 2023, and 52,550 are expected to die of this disease. In two recent studies, researchers addressed the impact of overweight, obesity, and body mass index (BMI) on colorectal and non-colorectal gastrointestinal (GI) cancers at different stages of adult life, as well as the association of BMI and different molecular subtypes in colorectal cancers.
Eliminating Underlying Liver Disease Remains Key Strategy for Liver Cancer Prevention
May 4, 2023 | By Susan JenksDespite intense research, liver cancer prevention remains a challenge. Current efforts are directed at underlying conditions that can significantly raise an individual’s risk, including hepatitis C infection, for which researchers are working to find a vaccine.